Published in Glycoconj J on June 10, 2014
Gangliosides: structure, isolation, and analysis. Methods Enzymol (1982) 3.20
Binding of influenza virus hemagglutinin to analogs of its cell-surface receptor, sialic acid: analysis by proton nuclear magnetic resonance spectroscopy and X-ray crystallography. Biochemistry (1992) 3.03
Fluorescence correlation spectroscopy relates rafts in model and native membranes. Biophys J (2004) 2.73
Physiology and pathophysiology of sphingolipid metabolism and signaling. Biochim Biophys Acta (2000) 1.77
Structure and function of a ganglioside receptor for porcine rotavirus. J Virol (1998) 1.39
Interferon action: role of membrane gangliosides. Virology (1976) 1.29
Mucosal adjuvant properties of mutant LT-IIa and LT-IIb enterotoxins that exhibit altered ganglioside-binding activities. Infect Immun (2005) 1.24
Versatile biosynthetic engineering of sialic acid in living cells using synthetic sialic acid analogues. J Biol Chem (2001) 1.22
Immunotherapy of advanced breast cancer with a heterophilic ganglioside (NeuGcGM3) cancer vaccine. J Clin Oncol (2003) 1.15
Thermodynamic consequences of disrupting a water-mediated hydrogen bond network in a protein:pheromone complex. Protein Sci (2005) 1.06
Clinical evidences of GM3 (NeuGc) ganglioside expression in human breast cancer using the 14F7 monoclonal antibody labelled with (99m)Tc. Breast Cancer Res Treat (2005) 1.05
Gangliosides as receptors for biological toxins: development of sensitive fluoroimmunoassays using ganglioside-bearing liposomes. Anal Chem (2000) 1.05
Cellular and humoral immune response to N-Glycolyl-GM3 elicited by prolonged immunotherapy with an anti-idiotypic vaccine in high-risk and metastatic breast cancer patients. J Immunother (2006) 1.03
Ganglioside GM3 promotes cell migration by regulating MAPK and c-Fos/AP-1. Oncogene (2006) 0.98
Conformation of the oligosaccharide chain of G(M1) ganglioside in a carbohydrate-enriched surface. Biophys J (1998) 0.98
X-Ray Diffraction Studies of the Cholera Toxin receptor, G(M1). Biophys J (1986) 0.97
Glycolipid receptors for verotoxin and Helicobacter pylori: role in pathology. Biochim Biophys Acta (1999) 0.97
Atomic-resolution conformational analysis of the GM3 ganglioside in a lipid bilayer and its implications for ganglioside-protein recognition at membrane surfaces. Glycobiology (2008) 0.96
Shiga toxin receptor glycolipid binding. Pathology and utility. Methods Mol Med (2003) 0.95
Binding to gangliosides containing N-acetylneuraminic acid is sufficient to mediate the immunomodulatory properties of the nontoxic mucosal adjuvant LT-IIb(T13I). Clin Vaccine Immunol (2010) 0.91
Conformations of higher gangliosides and their binding with cholera toxin - investigation by molecular modeling, molecular mechanics, and molecular dynamics. J Biomol Struct Dyn (2006) 0.88
Structural basis for the resistance of Tay-Sachs ganglioside GM2 to enzymatic degradation. J Biol Chem (1999) 0.87
Characterization of the conformational and orientational dynamics of ganglioside GM1 in a dipalmitoylphosphatidylcholine bilayer by molecular dynamics simulations. Biochim Biophys Acta (2007) 0.83
Structural insight into the interactions of SoxV, SoxW and SoxS in the process of transport of reductants during sulfur oxidation by the novel global sulfur oxidation reaction cycle. Biophys Chem (2005) 0.82
Sphingolipids in tumor metastases and angiogenesis. Biochemistry (Mosc) (2006) 0.81
Monosialogangliosides and their interaction with cholera toxin - investigation by molecular modeling and molecular mechanics. J Biomol Struct Dyn (2004) 0.79
Algorithmic approach for removing the redundancy in diabetic gene categories based on semantic similarity and gene expression data. Interdiscip Sci (2015) 0.77
Molecular simulation of N-acetylneuraminic acid analogs and molecular dynamics studies of cholera toxin-Neu5Gc complex. J Biomol Struct Dyn (2014) 0.76
Molecular modeling of methyl-α-Neu5Ac analogues docked against cholera toxin--a molecular dynamics study. Glycoconj J (2015) 0.75